By Batya Swift Yasgur, MA, LSW Walnuts have been associated with better cognitive development and psychological maturation in teens, new research shows. Adolescents who consumed walnuts for at least 100 days showed improved sustained attention and fluid intelligence as well as a reduction in symptoms of attention deficit hyperactivity disorder (ADHD) compared with matched controls who did not consume the nuts. However, there were no statistically significant changes between the groups in other parameters, such as working memory and executive function. Clinicians should advise adolescents “to eat a handful of walnuts three times a week for the rest of their lives. They may have a healthier brain with better cognitive function,” senior investigator Jordi Julvez, PhD, group leader at the Institute of Health Research Pere Virgili and associated researcher at the Barcelona Institute for Global Health, told Medscape Medical News. The study was published online April 6 in Lancet Discovery Science (eClinicalMedicine). Rich Source of Omega-3s Adolescence ...
Ending performance-related payments for NHS GPs in Scotland was associated with a decline in the quality of some aspects of care compared with England where financial incentives have continued, finds a study published by The BMJ today. The researchers say further research is needed to better understand the full impact of withdrawal and the accompanying refocusing of quality improvement resources. The NHS Quality and Outcomes Framework (QOF) pay-for-performance scheme began in 2004. It was designed to remunerate general practices for providing good quality care across a range of key areas such as cancer, diabetes, heart disease, mental health, and obesity. In 2016, Scotland abolished the QOF to reduce the bureaucratic burden on GPs and to free-up their time for patients, but continued collecting performance data for some QOF indicators for the next three years. Researchers were therefore able to use this data to evaluate the impact of ...
The outbreak of Covid-19 presented many dangers for children, and a new study suggests increased illicit substance ingestions were among them. In the first month of the pandemic in 2020, a 25% increase in overall ingestions occurred among children under 6 years old in the United States, according to the study published Friday in JAMA Network Open. Those numbers grew by 1.8% more per month than they did before the pandemic, the study said. “The immediate and sustained increase in opioids ingestions occurred during the largest ever rise in adult overdose deaths, largely driven by synthetic opioids,” said lead study author Dr. Brittany Raffa, a clinical instructor in pediatrics at the University of North Carolina at Chapel Hill and a National Research Service Award primary care research fellow. The study looked at data from 7,659 children under age 6 who were treated for ingestion of amphetamines, benzodiazepines, cannabis, cocaine, ethanol and ...
In a recent study published in the journal JAMA Network Open, researchers performed a meta-analysis to assess the co-occurrence of reproductive and psychiatric disorders among women. Disorders associated with the female mental well-being and reproductive tract commonly co-exist; however, the precise cause of the co-occurrence is not clear. Probable causes include non-intrinsic or external-type factors that interfere with the reproductive system, including psychotropic-type medications, psychosocial causes like reproductive disorders impacting relationships and life quality, and stress affecting reproductive functions and the menstrual cycle. Moreover, the overlap could originate from genetic causes. About the study In the present meta-analysis, researchers determined the association between female reproductive and psychiatric functions. The PubMed database was searched for observational-type and peer-reviewed studies (population-level cross-sectional and case-control studies), including reproductive-age females aged between 13.0 and 55.0 years, published from January 1980 to December 2019, evaluating the prevalence of mental health disorders among ...
A new study has found that virtual reality therapy may be an effective treatment for post-traumatic stress disorder (PTSD). PTSD is a mental health condition that can develop after experiencing or witnessing a traumatic event, such as military combat, sexual assault, or a natural disaster. Symptoms of PTSD can include flashbacks, nightmares, and anxiety. The study, published in The Lancet Psychiatry, involved 103 military veterans with PTSD. The veterans were randomly assigned to receive either virtual reality therapy or traditional therapy, which involved talk therapy and other forms of therapy. The virtual reality therapy involved wearing a headset that displayed virtual environments related to the veterans’ traumatic experiences. The veterans were able to interact with the virtual environments and practice coping strategies to manage their symptoms. The researchers found that the veterans who received virtual reality therapy had greater reductions in PTSD symptoms than those who received ...
Thrive, a wellbeing approved for use by the NHS, has raising a total of £2.5m in funding in only ten days, the digital health company has announced. The latest funding round attracted investment from the Sumerian Foundation and Treebeard Trust, as well as from investment platforms such as Syndicate Room and Wealth Club. In a statement, Thrive said it would use the new funding to research and identify further areas of help that it can support and also develop the tech platform further. This will include increased integration with existing medical data, with the aim of giving users ‘seamless’ access to mental health care. Currently, the app provides whole-person solutions for workplaces and individuals, and is designed to help users overcome periods of stress while supporting long-term mental health. It uses clinical-grade, evidence-based techniques to achieve this, while also providing in-app access to trained therapists. The company was initially launched ...
New results from a Phase IIIa study have demonstrated that Novo Nordisk’s weight loss drug semaglutide improved physical function and wellbeing among people with obesity. The STEP 1 trial demonstrated benefits for people with obesity treated with semaglutide 2.4mg ‘beyond weight loss’, Novo said in a statement. Over a 68-week period, treatment with once-weekly semaglutide 2.4mg was associated with greater improvements for all weight- and health-related quality of life scores in people with obesity or overweight in comparison to placebo. This included improved wellbeing, with 43.8% of patients treated with Novo’s drug achieving a clinically meaningful improvement in total weight-related quality of life score at week 68. On top of that, 51.2% of participants treated with semaglutide 2.4mg in the trial had an increased weight-related physical function score, reflecting improvements in the ability to perform daily activities. In addition, patients treated with semaglutide 2.4mg ‘simultaneously’ experienced significant weight loss of ...
A recent 5-year study on 221,677 individuals aged 45 and above devoid of having a stroke or cardiac arrest in their medical history, revealed that mental disorders like anxiety and depression could increase the chances of the occurrence of a cardiac arrest or stroke.
A research team from the University of Pennsylvania in Philadelphia has suggested the several inexpensive ways of cleaning trash and the plantation of new grass and trees in vacant lands might reduce peoples’ feelings of worthlessness and depression.
Kindbody, a women-empowered startup was launched on Tuesday by Gina Bartasi, Progyny founder and other women leaders, remarkably co-founders Fahimeh Sasan, MD, from Mount Sinai, and Joanne Schneider, former product leader at Google and Flatiron Health, and Cynthia Hudson, clinical embryology and IVF expert and owner of Manhattan Fertility Specialists.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.